Author

B. Kong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Shao· 1 shared G. Lu· 1 shared H. Guo· 1 shared H. Liu· 1 shared J. Qin· 1 shared L. Wu· 1 shared S. Wang· 1 shared X. ZhangiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Shao

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12

Z. Wang, S. Wang, J. Qin, X. Zhang, G. Lu, H. Liu, H. Guo, L. Wu, C. Shao, B. Kong, Z. Liu

This study identifies BUD31 as a splicing factor that promotes ovarian cancer by maintaining anti-apoptotic BCL2L12 expression through exon inclusion.

Nature Communications · Oct 21, 2022Peer-reviewedCancer Biology